Sayed Ali

723 total citations
25 papers, 530 citations indexed

About

Sayed Ali is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sayed Ali has authored 25 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sayed Ali's work include Cancer Immunotherapy and Biomarkers (9 papers), Melanoma and MAPK Pathways (6 papers) and CAR-T cell therapy research (3 papers). Sayed Ali is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Melanoma and MAPK Pathways (6 papers) and CAR-T cell therapy research (3 papers). Sayed Ali collaborates with scholars based in Australia, United States and Saudi Arabia. Sayed Ali's co-authors include Howard Gurney, James Kuo, Beixue Gao, Aine Clements, Mitali Fadia, Desmond Yip, Deepak Kilari, Jiali Wang, Alexander M. Menzies and Sreedevi K. Menon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Sayed Ali

23 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sayed Ali Australia 13 307 188 134 85 60 25 530
Yoshitaka Seki Japan 13 175 0.6× 107 0.6× 110 0.8× 38 0.4× 75 1.3× 38 424
Lazar Popović Serbia 12 268 0.9× 113 0.6× 160 1.2× 53 0.6× 69 1.1× 43 455
Ekaphop Sirachainan Thailand 12 264 0.9× 84 0.4× 80 0.6× 42 0.5× 49 0.8× 37 432
Sarah Troutman United States 8 169 0.6× 173 0.9× 91 0.7× 28 0.3× 70 1.2× 13 362
Ye Cao China 11 183 0.6× 87 0.5× 86 0.6× 48 0.6× 79 1.3× 32 477
Nanya Wang China 13 148 0.5× 150 0.8× 79 0.6× 120 1.4× 71 1.2× 29 450
Faye Turner United Kingdom 13 263 0.9× 250 1.3× 71 0.5× 37 0.4× 76 1.3× 15 529
Elsa Curtit France 11 216 0.7× 76 0.4× 106 0.8× 41 0.5× 115 1.9× 45 441
John Hayslip United States 14 164 0.5× 510 2.7× 111 0.8× 50 0.6× 79 1.3× 29 962
Xin Cai China 14 288 0.9× 120 0.6× 103 0.8× 129 1.5× 53 0.9× 39 638

Countries citing papers authored by Sayed Ali

Since Specialization
Citations

This map shows the geographic impact of Sayed Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sayed Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sayed Ali more than expected).

Fields of papers citing papers by Sayed Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sayed Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sayed Ali. The network helps show where Sayed Ali may publish in the future.

Co-authorship network of co-authors of Sayed Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Sayed Ali. A scholar is included among the top collaborators of Sayed Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sayed Ali. Sayed Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ali, Sayed, Mohammad Khalaj‐Kondori, Mohammad Ali Hosseinpour Feizi, & Mehdi Haghi. (2024). Expression Levels of miR -124a, miR-545-3p and BDNF in the Peripheral Blood Mononuclear Cells Are Associated with the Severity of Autism. PubMed. 13(1). 1–12.
2.
Lin, Chung‐Wu, Muhammad Adnan Khattak, Thomas Ferguson, et al.. (2024). Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Insights from the Western Australian Context. SHILAP Revista de lepidopterología. 12(10). 257–257. 2 indexed citations
3.
O’Connor, Moira, et al.. (2022). “Who can I ring? Where can I go?” Living with advanced cancer whilst navigating the health system: a qualitative study. Supportive Care in Cancer. 30(8). 6817–6826. 6 indexed citations
4.
Kelly, Greg, Fares Al‐Ejeh, Robert McCuaig, et al.. (2021). G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma. Clinical Cancer Research. 27(9). 2624–2635. 29 indexed citations
5.
6.
McCuaig, Robert, Kristine Hardy, Nabila Seddiki, et al.. (2020). Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch. Frontiers in Immunology. 11. 1228–1228. 49 indexed citations
7.
Fadia, Mitali, et al.. (2020). PD-L1 expression in papillary thyroid cancer with and without lymphocytic thyroiditis: a cross sectional study. Pathology. 52(3). 318–322. 13 indexed citations
8.
O’Connor, Moira, Christobel Saunders, Rachael Moorin, et al.. (2020). The role of psychosocial support in the experiences of people living with advanced cancer: A qualitative exploration of patients' perspectives. Psycho-Oncology. 30(3). 287–295. 11 indexed citations
9.
Pavli, Paul, et al.. (2019). Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report. World Journal of Clinical Oncology. 10(10). 350–357. 9 indexed citations
10.
Ahmed, Shakeel, et al.. (2019). Prevalence of Night Eating Syndrome amongst Medical Students in Saudi Arabia. International Journal of Medicine in Developing Countries. 22–25. 9 indexed citations
11.
Parakh, Sagun, Lydia Warburton, Mohammad Akhtar Hussain, et al.. (2018). Real‐world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma. Asia-Pacific Journal of Clinical Oncology. 15(1). 26–30. 17 indexed citations
12.
Fadia, Mitali, et al.. (2017). PD‐L1 expression associated with worse survival outcome in malignant pleural mesothelioma. Asia-Pacific Journal of Clinical Oncology. 14(1). 69–73. 32 indexed citations
13.
Singavi, Arun K., Sreedevi K. Menon, Deepak Kilari, et al.. (2017). Predictive biomarkers for hyper-progression (HP) in response to immune checkpoint inhibitors (ICI) – analysis of somatic alterations (SAs). Annals of Oncology. 28. v405–v405. 60 indexed citations
14.
Fox, Peter, Rosemary L. Balleine, Bo Gao, et al.. (2016). Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study. Clinical Cancer Research. 22(13). 3164–3171. 64 indexed citations
15.
Ali, Sayed, et al.. (2016). Unusual side effects of anti-PD1 checkpoint inhibitors in the treatment of stage IV melanoma. ANU Open Research (Australian National University).
16.
Kuo, James, et al.. (2016). Two cases of clinical myasthenia gravis associated with pembrolizumab use in responding melanoma patients. Melanoma Research. 27(2). 152–154. 52 indexed citations
17.
Parakh, Sagun, Hui‐Li Wong, Rajat Rai, et al.. (2015). Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia. Journal of Geriatric Oncology. 6(5). 387–394. 20 indexed citations
18.
Fox, Peter, Bo Gao, Bavanthi Balakrishnar, et al.. (2013). Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation.. Journal of Clinical Oncology. 31(15_suppl). 543–543. 2 indexed citations
19.
Parakh, Sagun, Sayed Ali, Hui‐Li Wong, et al.. (2013). Patterns of care of elderly patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 31(15_suppl). e14640–e14640. 3 indexed citations
20.
Clements, Aine, et al.. (2011). Metformin in prostate cancer: two for the price of one. Annals of Oncology. 22(12). 2556–2560. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitaka Seki Breakdown of academic impact, for papers by Lazar Popović Breakdown of academic impact, for papers by Ekaphop Sirachainan Breakdown of academic impact, for papers by Sarah Troutman Breakdown of academic impact, for papers by Ye Cao Breakdown of academic impact, for papers by Nanya Wang Breakdown of academic impact, for papers by Faye Turner Breakdown of academic impact, for papers by Elsa Curtit Breakdown of academic impact, for papers by John Hayslip Breakdown of academic impact, for papers by Xin Cai
Rankless by CCL
2026